Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In this randomized, placebo-controlled trial, 667 patients with stable advanced multiple sclerosis were assigned to 1 of 3 groups: oral cannabis, oral tetrahydrocannabinol, or placebo.

Going to Pot with MS?